✦ LIBER ✦

Lentiviral mediated stem cell gene therapy corrects a mouse model of mucopolysaccharidosis type IIIA

✍ Scribed by Brian Bigger; Alex Langford-Smith; Fiona Wilkinson; Kia Langford-Smith; Ana Sergijenko; Ed Wraith; Rob Wynn

Book ID: 116989124
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 102
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2010.11.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myeloid driven stem cell gene therapy co

Myeloid driven stem cell gene therapy corrects a mouse model of Mucopolysaccharidiosis IIIA

✍ Sergijenko, Ana; Langford-Smith, Alexander; Liao, Ai Yin; Pickford, Claire; McDe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Correction of mucopolysaccharidosis type

Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transfer

✍ Chantelle McIntyre; Sharon Byers; Donald S. Anson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract ## Background The hallmark of lysosomal storage disorders (LSDs) is microscopically demonstrable lysosomal distension. In mucopolysaccharidosis type IIIA (MPS IIIA), this occurs as a result of an inherited deficiency of the lysosomal hydrolase sulphamidase. Consequently, heparan sulpha

86. Ex vivo lentiviral gene transfer tar

86. Ex vivo lentiviral gene transfer targeting hematopoietic stem cells for therapy of mucopolysaccharidosis type II, Hunter syndrome

✍ R. Scott McIvor; Daniel A. Wolf; Kelly Podetz-Petersen; Zhenhong Nan; Chester B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Characterization of a novel mucopolysacc

Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy

✍ Sung-Chul Jung; Eun-Sook Park; Eun Nam Choi; Chi Hwa Kim; Su Jin Kim; Dong-Kyu J 📂 Article 📅 2010 🏛 Korean Society for Molecular and Cellular Biology 🌐 English ⚖ 835 KB

In vitro characterization of genetically

In vitro characterization of genetically modified embryonic stem cells as a therapy for murine mucopolysaccharidosis type IIIA

✍ Adeline A Lau; Kim M Hemsley; Adrian Meedeniya; John J Hopwood 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Evaluation of fibroblast-mediated gene t

Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI

✍ Gouri Yogalingam; Allison Crawley; John J Hopwood; Donald S Anson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 277 KB